Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07062939

Comparative Effects of Mechanical and Manual Airway Clearance Techniques in Cystic Fibrosis

This study will help to establish evidence-based physiotherapy on postural drainage and ACBT against flutter with ACBT is better to improve sleep quality, adherence, dyspnea in patients with cystic fibrosis and which method can improve respiratory function, reduce the risk of complications after illness and additionally advancements in respiratory therapy can lead to improve sleep quality, individual preference and adherence and dyspnea.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

16 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

DHQ Hospital

Sheikhupura, Punjab Province, 39350, Pakistan

Location contact

Fibha sherwani, MSCPPT

PRINCIPAL_INVESTIGATOR

Iram Nawaz, mphill

CONTACT

[email protected]

03324645227

About this study

Cystic fibrosis (CF) is a genetic disorder that leads to the accumulation of thick mucus in the lungs and other organs, resulting in recurrent infections and progressive lung damage. This condition is due to mutations in the cystic fibrosis transmembrane conductance regulator CFTR gene, which governs the transport of chloride and other ions across cell membranes. CF affects a significant number of people worldwide, with certain genetic mutations leading to more severe manifestations of the disease. The management of CF is centered on clearing the airways of mucus to prevent infections and slow the progression of lung damage. Various studies have yielded inconsistent results regarding the comparative effectiveness of manual versus mechanical airway clearance techniques in improving pulmonary function tests (PFTs) in CF patients.

Despite the existing literature on postural drainage with ACBT in patient with cystic fibrosis, there is a significant research gap regarding the flutter and ACBT on the bases of outcomes in cystic fibrosis. Most studies have not adequately addressed the distinct needs and responses of flutter with ACBT on the basis of outcomes, leaving a void in understanding how these two intervention effect on sleep, adherence and dyspnea in the context of patients with cystic fibrosis. Closing this gap is essential for developing evidence-based and pulmonary rehabilitation techniques for this specific patient group.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient having clinically diagnose Cystic fibrosis.
  • Age 16-40 year.
  • Both male and female.
  • Subjects who are conscious and cooperative .

Exclusion criteria

  • Rib fracture
  • History of cardiac surgery.
  • Subject with any Physical or Mental Disability
  • Age less than 16 years

Treatment and study plan

postural drainage with ACBT

Other

postural drainage and ACBT for 2 times a day for 30 min for 4 weeks.

flutter with ACBT

Other

flutter with active cycle breathing technique for 30 min. for 4 week and 2 times a day.

Primary outcomes

  1. The Pittsburgh Sleep Quality Index (PSQI)

    Time frame: 4 weeks

    This is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval, show the sleep quality duration and efficacy. Many of the aforementioned research employed the PSQI, the most commonly utilized sleep quality index. the validity and reliability of the PSQI in healthcare professionals, or even in high-pressure shift employees. The PSQI's validity and reliability in regularly planned, low-pressure groups, such as adults in good health who live in the vicinity, differed greatly from front-line COVID-19 healthcare personnel. The conventional test theory (CTT) serves as the primary foundation for the reliability and validity research on PSQI. While there is little to no link between the PSQI and problems including anger, nausea,stiffness, and urinary disorder, it does have a strong correlation with the Insomnia Severity Index, polysomnography, and other sleep quality indicators

  2. The Shwachman-Kulczycki score

    Time frame: 4 weeks

    This is the first scoring system used in cystic fibrosis to assess disease severity and show the adherence to treatment. In the present study, the total Shwachman-Kulczycki score correlated positively with the scores for each of its four domains, and physical activity was the aspect that most influenced total score.

  3. Borg dyspnea scale

    Time frame: 4 weeks

    The instruments provide a standard method for patients to select ratings of dyspnea on a scale based on descriptors that correspond to specific numbers

Secondary outcomes

  1. The Breathlessness, Cough and Sputum Scale (BCSS)

    Time frame: 4 weeks

    This scale is used to predict patient exacerbations by evaluating common symptoms, Results suggest BCSS scores are valid indicators of the severity of cough and sputum in patients with COPD. Scores for both items were correlated with sputum volume.

Study contacts

Contact information is provided by the study sponsor or research team.

imran amjad, phD

CONTACT

[email protected]

03324390125

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Comparative Effects of Manual Versus Mechanical Airway Clearance Techniques in Cystic Fibrosis

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jul 14, 2025
Registry last updated
Jul 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.